Cindy Boer

274 | Chapter 6 23. Hatzikotoulas, K., et al., Genome-wide association study of developmental dysplasia of the hip identifies an association with GDF5. Commun Biol, 2018. 1: p. 56. 24. Visscher, P.M., et al., 10 Years of GWAS Discovery: Biology, Function, and Translation, in Am J Hum Genet. 2017. p. 5-22. 25. Gabriel, S.B., et al., The structure of haplotype blocks in the human genome. Science, 2002. 296(5576): p. 2225-9. 26. Maurano, M.T., et al., Systematic localization of common disease-associated variation in regulatory DNA. Science, 2012. 337(6099): p. 1190-5. 27. Mumbach, M.R., et al., Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elements. Nat Genet, 2017. 49(11): p. 1602-12. 28. Brodie, A., J.R. Azaria, and Y. Ofran, How far from the SNP may the causative genes be? 2016. 29. Ibrahim, D.M. and S. Mundlos, Three-dimensional chromatin in disease: What holds us together and what drives us apart? Curr Opin Cell Biol, 2020. 64: p. 1-9. 30. Kundaje, A., et al., Integrative analysis of 111 reference human epigenomes. Nature, 2015. 518(7539): p. 317-30. 31. Nelson, M.R., et al., The support of human genetic evidence for approved drug indications. Nat Genet, 2015. 47(8): p. 856-60. 32. King, E.A., J.W. Davis, and J.F. Degner, Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the prob- ability of drug approval. PLoS Genet, 2019. 15(12): p. e1008489. 33. Schurgers, L.J., E.C. Cranenburg, and C. Vermeer, Matrix Gla-protein: the calcification inhibitor in need of vitamin K. Thromb Haemost, 2008. 100(4): p. 593-603. 34. Misra, D., et al., Vitamin K deficiency is associated with incident knee osteoarthritis. Am J Med, 2013. 126(3): p. 243-8. 35. Neogi, T., et al., Low vitamin K status is associated with osteoarthritis in the hand and knee. Arthri- tis Rheum, 2006. 54(4): p. 1255-61. 36. Neogi, T., et al., Vitamin K in hand osteoarthritis: results from a randomised clinical trial. Ann Rheum Dis, 2008. 67(11): p. 1570-3. 37. Zhu, J., et al., Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010-2017. Pharmacotherapy, 2018. 38(9): p. 907-20. 38. Shea, M.K., et al., Association of Vitamin K Status Combined With Vitamin D Status and Lower-Ex- tremity Function: A Prospective Analysis of Two Knee Osteoarthritis Cohorts. Arthritis Care Res (Hoboken), 2018. 70(8): p. 1150-1159. 39. Shea, M.K., et al., The association between vitamin K status and knee osteoarthritis features in older adults: the Health, Aging and Body Composition Study. Osteoarthritis Cartilage, 2015. 23(3): p. 370-8. 40. Styrkarsdottir, U., et al., Severe osteoarthritis of the hand associates with common variants within the ALDH1A2 gene and with rare variants at 1p31. Nat Genet, 2014. 46(5): p. 498-502. 41. Meulenbelt, I., et al., Identification of DIO2 as a new susceptibility locus for symptomatic osteoar- thritis. Hum Mol Genet, 2008. 17(12): p. 1867-75. 42. Capellini, T.D., et al., Ancient selection for derived alleles at a GDF5 enhancer influencing human growth and osteoarthritis risk. Nat Genet, 2017. 49(8): p. 1202-1210. 43. Falony, G., et al., Population-level analysis of gut microbiome variation. Science, 2016. 352(6285): p. 560-4. 44. Jackson, M.A., et al., Gut microbiota associations with common diseases and prescription medica- tions in a population-based cohort. Nat Commun, 2018. 9(1): p. 2655. 45. Neogi, T., The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage, 2013. 21(9): p. 1145-53.